Welcome to our dedicated page for Leidos Holdings SEC filings (Ticker: LDOS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Leidos Holdings, Inc. (NYSE: LDOS) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a large technology, engineering and science company serving defense, civil, health and commercial markets, Leidos uses these filings to report on its financial condition, operations, risks and material events.
Investors can review annual reports on Form 10-K and quarterly reports on Form 10-Q for detailed information on segment performance across National Security & Digital, Health & Civil, Commercial & International and Defense Systems. These reports typically include discussions of contract activity, backlog, mission areas such as national security, aviation security, energy efficiency programs and civil space work, as well as risk factors relevant to government contracting and technology-focused services.
Current reports on Form 8-K capture significant developments, including the release of quarterly financial results and other material events. For example, Leidos has filed an 8-K to furnish a press release announcing financial results for a fiscal quarter and to provide details on its earnings conference call. Such filings help investors understand short-term performance changes and key operational updates.
Stock Titan’s platform surfaces these LDOS filings in real time as they are posted to EDGAR and adds AI-powered summaries to explain the main points of lengthy documents. This can help readers quickly identify items such as revenue trends, segment commentary, major contract awards, or updates related to programs in areas like national security, air traffic management or energy efficiency. Users can also track insider transaction reports on Form 4, proxy statements on Schedule 14A and other relevant forms to gain additional insight into executive compensation, governance and insider trading activity.
By combining timely EDGAR updates with AI-generated explanations, this page is designed to make Leidos’ SEC reporting more accessible to both experienced analysts and individual investors researching LDOS stock.
Leidos Holdings reported an insider stock sale by Sector President Elizabeth A. Porter. On January 20, 2026, Porter sold 3,000 shares of Leidos common stock at a weighted average price of $192.2117 per share, in multiple trades priced between $192.17 and $192.36. The sale was executed under a pre-arranged Rule 10b5-1 trading plan that Porter entered into on September 12, 2025. Following this transaction, she beneficially owns 38,575 shares of Leidos common stock directly.
Leidos Holdings has a Form 144 notice indicating an affiliated seller plans to sell 3,000 shares of its common stock through Citigroup Global Markets on the NYSE, with an aggregate market value of $584,100 as of the filing. These shares were acquired on 01/20/2026 from Leidos Holdings Inc. as vested shares for services rendered and are part of the company’s 127,855,172 shares outstanding.
The notice also reports that the same seller disposed of 3,000 Leidos common shares on 12/19/2025 for gross proceeds of $543,129. By signing the notice, the seller represents they do not know of any undisclosed material adverse information about Leidos’ current or future operations.
Leidos Holdings, Inc. Sector President Jason M. O'Connor reported his equity holdings in the company. He directly beneficially owns 9,485 shares of common stock, which include restricted share units previously awarded.
He also holds a stock option for 1,564 shares of common stock with an exercise price of $133.06 per share. This option award is scheduled to vest in three equal annual installments beginning on March 7, 2026, continuing over the following two years.
Leidos Holdings director defers board fees into company stock. Director Harry M. Jansen Kraemer, Jr. reported an acquisition of 171.6596 shares of Leidos Holdings, Inc. common stock on 01/07/2026. These shares represent a quarterly payment of his retainer for serving on the Board of Directors, which he elected to receive in stock under the Leidos Holdings, Inc. Key Executive Stock Deferral Plan rather than in cash. After this deferral, he beneficially owns 128,811.1423 shares indirectly through the Key Executive Stock Deferral Plan and separately holds 91,360 shares directly.
Leidos Holdings, Inc. director Robert S. Shapard reported a small change in his ownership of company stock. On 12/31/2025, he acquired 3.7915 shares of common stock at a price of $0, described as dividend equivalent rights credited under a Key Executive Stock Deferral Plan. Following this transaction, he indirectly holds 1,620.4763 shares through the deferral plan, 2,500 shares through a family limited partnership, and directly owns 57,078.08 shares of Leidos common stock. This filing reflects routine equity-based compensation rather than an open‑market stock purchase or sale.
Leidos Holdings director reports additional stock units from dividend equivalents. A Leidos Holdings, Inc. (LDOS) director filed a statement of beneficial ownership covering a transaction dated 12/31/2025. The filing shows an acquisition of 305.0167 shares of common stock at a price of $0, credited through dividend equivalent rights under a Key Executive Stock Deferral Plan. After this transaction, the director beneficially owned 128,639.4827 shares indirectly through the deferral plan and 91,360 shares directly. The dividend equivalent rights noted in the explanation indicate the award reflects dividends on previously deferred equity, rather than an open-market stock purchase.
Leidos Holdings, Inc. officer reports dividend-equivalent stock accrual
A Leidos Holdings, Inc. Sector President filed a Form 4 reporting an automatic credit of 4.2527 shares of common stock on 12/31/2025, described as dividend equivalent rights under a Key Executive Stock Deferral Plan. These shares were acquired at a stated price of $0 and are held indirectly through the Key Executive Stock Deferral Plan, bringing the officer’s indirect beneficial ownership under that plan to 1,792.5419 shares of common stock. The filing also shows direct beneficial ownership of 49,934 shares of Leidos common stock.
Leidos Holdings, Inc. Chief Financial Officer Christopher R. Cage reported a routine change in his ownership of company stock. On 12/31/2025, he acquired 58.8718 shares of Leidos common stock at a price of $0, credited through dividend equivalent rights under the company’s Key Executive Stock Deferral Plan. After this transaction, he beneficially owned 29,401.5352 shares indirectly through the deferral plan and 46,680 shares directly of Leidos common stock. The filing characterizes the acquisition as based on dividend equivalent rights, which means cash dividends are credited in the form of additional stock units rather than cash.
Leidos Holdings, Inc. executive vice president and general counsel Daniel J. Antal reported a small change in his ownership of company stock. On 12/31/2025, he acquired 0.9791 shares of common stock as dividend equivalent rights at a price of $0, increasing his indirect holdings in the Key Executive Stock Deferral Plan to 5,009.4423 shares. In addition, he holds 13,047 shares of common stock directly. This filing records the updated beneficial ownership positions for this officer.
Leidos Holdings reported an insider stock sale by a senior executive. The company’s Sector President, a reporting officer, sold 2,303 shares of common stock on 12/19/2025 at a weighted average price of $180.89, and an additional 697 shares the same day at a weighted average price of $181.55. These transactions were carried out under a pre-arranged trading plan entered into on September 12, 2025 in accordance with Rule 10b5-1. Following these sales, the officer directly beneficially owns 41,575 shares of Leidos common stock.